Skip to content

A study to improve our understanding of the genetic causes of swelling in babies before birth

An Investigation into the aetiology and genetics of fetal oedema/hydrops with a focus on lymphatic related hydrops

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN22076461
Enrollment
60
Registered
2020-03-05
Start date
2019-07-27
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal oedema/hydrops with a focus on lymphatic related hydrops Pregnancy and Childbirth Conditions involving the integument and temperature regulation of fetus and newborn

Interventions

PART 1- RETROSPECTIVE AETIOLOGY Study (AIM 1) Three years’ worth of retrospective data regarding all pregnancies meeting the inclusion criteria will be gathered from the five collaborating fetal medic

Sponsors

St George’s University Hospitals NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. All cases of fetal hydrops at any gestation (as defined by the abnormal accumulation of fluid in two or more fetal compartments) 2. All cases of single compartment oedema (the abnormal accumulation of fluid within a fetal body cavity, for example, ascites, isolated hydrothoraces, generalised skin oedema) 3. Fetuses with a Nuchal Translucency (NT) >4.5mm at the 12/40 ultrasound scan. 4. Individuals affected by fetal oedema or hydrops in-utero for whom no explanation has been identified

Exclusion criteria

Exclusion criteria: Pregnancies with evidence of Rh or other blood group incompatibility (immune hydrops)

Design outcomes

Primary

MeasureTime frame
Part 1. Measurement of various indices from an ultrasound examination of affected pregnancy Part 2. Information regarding fetal outcome/ child health and development, via a telephone interview with parents, at one year in children with a specific genotype Part 3. Identification of sequence variants from genomic data sets

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026